ATR · NYSE
AptarGroup, Inc.
$137.58 +6.77 (+5.18%)
Company overview
AptarGroup, Inc. provides dispensing, sealing, and material science solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment offers pumps for nasal allergy treatments, metered dose inhaler valves for respiratory ailments such as asthma and COPD, elastomer components for injectable packaging, and active material science solutions. The Beauty + Home segment sells pumps, closures, aerosol valves, accessories, and sealing solutions to personal care and home care markets, as well as pumps and decorative components to the beauty industry. The Food + Beverage segment provides dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NYSE
- Market cap
- $8.7B
- Employees
- 13,000
- Headquarters
- Crystal Lake, IL
- Website
- aptar.com
- CEO
- Stephan Tanda
- Listed
- April 23, 1993
- P/E
- 23.28
- Dividend yield
- 1.43%
Company financials
- Revenue
- $3.9B
- Gross profit
- $1.1B
- Operating income
- $504M
- EBITDA
- $802M
- Net income
- $387M
- EPS
- $5.91
- Total assets
- $5.1B
- Total debt
- $1.4B
- Gross margin
- 28.99%
- Net margin
- 9.98%
- Earnings yield
- 4.30%
Showing FY 2025
ATR
1D
NYSE
O128.63H131.03L128.36C130.64+3.47 (+2.73%)Vol649.74K